Fluorescent scaffold-based og a glycosidase fluorescent probes, methods of construction and use thereof
By modifying the structure of the OGA glycosidase fluorescent probe, the accuracy problem of OGA activity detection in existing technologies has been solved, enabling precise detection and imaging of OGA activity in live cells and tissue sections, and providing a new research tool.
Patent Information
- Application Number
- CN202611266551.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-20
- Publication Date
- 2026-11-17
AI Technical Summary
Existing methods for detecting OGA glycosylation enzymes mainly rely on immunoblotting technology, which is easily affected by fluctuations in OGT activity and the non-specific binding of anti-O-GlcNAc antibodies. Furthermore, fluorescent probes with natural GlcNAc structures are easily cleaved by lysosomal enzymes, leading to signal interference and making it difficult to accurately measure OGA activity in complex biological systems.
A fluorescent probe for OGA glycosidase based on a fluorescent backbone was designed. By modifying the structure of the amide bond 2 of natural oxyacetylglucosamine and connecting it to a non-natural GlcNAc structure, a self-sacrificing structure was formed. This allows the probe to generate a fluorescent signal after OGA recognition, thus achieving specific recognition and detection of OGA.
It enables precise detection of OGA activity in live cells and tissue sections, reduces background interference, allows for in-situ imaging, distinguishes between cancerous and adjacent tissues, and provides a new tool for studying OGA function.
Smart Images

Figure CN123106792A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biodetection technology and provides the construction of OGA glycosidase fluorescent probes, specifically involving the construction method of OGA glycosidase fluorescent probes based on fluorescent backbones and their imaging applications in cells or tissues. Background Technology
[0002] O-GlcNAc glycosylation plays a crucial role in regulating cellular functions such as cell growth, division, differentiation, and development by reversibly modifying acetylglucosamine onto serine / threonine residues in proteins. Abnormalities in this biochemical process are associated with various pathological conditions and may ultimately lead to cancer and neurodegenerative diseases.
[0003] The O-GlcNAc glycosylation of proteins is dynamically regulated by the inverse action of O-GlcNAc glycosyltransferases (OGTs) and O-GlcNAc hydrolases (OGAs). Chemical probes developed for OGTs primarily rely on metabolic labeling strategies, which have led to several innovative discoveries demonstrating that OGTs are involved in regulating multiple signaling pathways related to cellular protein homeostasis, cardiac function, and cancer.
[0004] OGA removes O-glycosidic bonds from acetylglucosamine (GlcNAc) residues on serine / threonine residues in proteins. Previous studies have shown that OGA participates in a range of physiological and disease-related functional regulation. However, current methods for detecting OGA activity mainly rely on indirect analysis of overall O-GlcNAc conversion levels using Western blotting. This method is susceptible to fluctuations in OGT activity and the non-specific binding of anti-O-GlcNAc antibodies. Therefore, activation-type fluorescent small molecule probes for direct detection of OGA activity are being developed. However, molecular probes using natural GlcNAc as the reactive group often lack sufficient selectivity for OGA because the GlcNAc structure at the reaction site can be cleaved by acetamidohexosidase (HEX) in lysosomes, causing signal interference and hindering accurate measurement of OGA activity in complex biological systems. Therefore, synthesizing fluorescent probes selective for OGA is of great significance for in-situ analysis of changes in OGA activity. Summary of the Invention
[0005] This invention addresses the aforementioned problems by providing a small molecule fluorescent probe capable of specifically recognizing the activity of a single glycosidase, OGA, for studying the important functions of the target glycosidase in vivo, particularly its association with various diseases, thus providing new insights into the occurrence and treatment of diseases.
[0006] This invention yields a series of novel glycosidase probe structures through chemical modification of the sugar side chain structure. By structurally modifying the amide bond at position 2 of the natural oxyacetylglucosamine and coupling it with a fluorescent backbone (such as the Rhodol fluorescent backbone), the compound can be specifically recognized by OGA and hydrolyzed to generate a fluorescent signal. This results in novel fluorescent probes capable of accurately detecting OGA activity in living cells and tissues, providing a new and effective tool for subsequent research on the physiological and pathological functions of OGA.
[0007] Specific experimental results showed that, compared with fluorescent probes obtained by coupling natural oxyacetylglucosamine with a fluorescent backbone, the non-natural GlcNAc structure coupled fluorescent backbone probe designed in this invention can only be recognized by OGA and does not react with other enzymes, thus successfully realizing the in situ detection of OGA activity in live cells and tissue sections.
[0008] Based on the above research, the technical solution to be protected by this invention is as follows:
[0009] In a first aspect, this invention provides a fluorescent probe for OGA glycosidase based on a fluorescent backbone, which is obtained by linking non-natural GlcNAc structures modified with different structures to a fluorescent dye backbone via a self-sacrificing structure. Before being recognized by OGA, the fluorescent backbone is in a closed-ring state; upon recognition by OGA, the glycosyl groups are hydrolyzed, thereby converting the dye into a fluorescent open-ring form, thus enabling the catalytic activity of OGA.
[0010] Preferably, the fluorescent dye backbone in this invention is selected from any one of Rhodol fluorescent backbone, naphthimide, hemicyanine, and malononitrile dyes;
[0011] In a preferred embodiment of the present invention, the fluorescent dye backbone is preferably derived from the Rhodol fluorescent backbone.
[0012] Based on this, the present invention provides a general formula for OGA glycosidase fluorescent probe structure as shown in Formula I, which is obtained by linking non-natural GlcNAc structures modified with different structures to the fluorescent dye Rhodol.
[0013]
[0014] Formula I
[0015] In the formula, R1 represents different GlcNAc-derived glycosyl groups, selected from any of the following structures:
[0016]
[0017] R2, R3, R4, and R5 are modifying groups on the fluorophore, with specific structures of any of the following: -H, -F, -Cl, -Br.
[0018] R6 can be modified with other functional groups, specifically any of the following structures: -H, -COOH, -NH2.
[0019] R7 is the backbone structure at the N-terminus of the dye, specifically any of the following structures:
[0020]
[0021] R8 represents a cyclic connection form, specifically any of the following structures: -CH2, -C=O;
[0022] X is the core structure that affects the optical properties of the dye, and its specific structure can be any of the following:
[0023]
[0024] L represents the linkage between the sugar and the dye, which can be either directly linked via an O-glycosidic bond or by introducing a self-sacrificial bridge structure. The specific structure can be any of the following:
[0025]
[0026] R9, R10, R11, and R12 are modifying groups on the benzene ring, with any of the following structures: -H, -NO2.
[0027] The fluorescent probe of this invention has no fluorescent signal before contacting OGA. When recognized by OGA, the sugar group is hydrolyzed, thereby converting the dye Rhodol into a fluorescent ring-opening form, thus activating the catalytic activity of OGA. The specific reaction principle is as follows:
[0028]
[0029] In a second aspect, the present invention provides a method for preparing the OGA glycosidase fluorescent probe described above, comprising the following steps:
[0030] (1) Add magnetic particles, alkaline catalyst and desiccant to the reaction vessel, and replace the air in the system with inert gas multiple times to prepare an anhydrous and oxygen-free reaction environment;
[0031] (2) Dissolve GlcNAc derivatized sugars and Rhodol dyes in organic solvents respectively, add them sequentially to the reaction vessel under an inert gas atmosphere, and stir the reaction at room temperature under inert gas protection until complete, and then remove the organic solvent by rotary evaporation.
[0032] (3) Extraction was performed using organic solvent and saturated brine, respectively. The organic phase was collected, dried with a desiccant, and then rotary evaporated to obtain a red oily crude product. The intermediate of the acetyl protected probe was separated and purified by DCM / MeOH column chromatography. It was directly added to the next reaction without further purification. The intermediate of the acetyl protected probe was dissolved in methanol solution. Sodium methoxide was slowly added to the reaction system and the reaction was stirred. After the reaction was completed by TLC monitoring, methanol was removed by rotary evaporation. The OGA glycosidase fluorescent probe was obtained by separation and purification by DCM / MeOH column chromatography (DCM / MeOH = 95:5→85:15, v / v).
[0033] Preferably, in steps (1) and (3), the desiccant is selected from any one of anhydrous sodium sulfate, anhydrous calcium sulfate, 3A or 4A molecular sieve, with anhydrous sodium sulfate being preferred.
[0034] In step (1), the equivalent ratio between the alkaline catalyst and the desiccant is 5:4;
[0035] The alkaline catalyst is selected from either cesium carbonate or potassium carbonate, with cesium carbonate being preferred, to promote CO bond formation by utilizing the special coordination ability of cesium ions;
[0036] The inert gas is selected from double-row argon gas, and the replacement is performed at least 3 times to ensure an oxygen-free environment in the reaction system.
[0037] In step (2), the organic solvent is selected from any one of acetonitrile, methanol, isopropanol, acetone, and tetrahydrofuran, with acetonitrile being preferred;
[0038] The amounts of GlcNAc-derived glycosyl group and Rhodol dye added were 2 equivalents (eq) and 1 equivalent (eq), respectively.
[0039] In step (3), the organic solvent is selected from dichloromethane (DCM), ethyl acetate, 2-methyltetrahydrofuran or methyl isobutyl ketone, preferably dichloromethane;
[0040] When separating and purifying the intermediate of the acetyl protected probe by column chromatography, a DCM / MeOH gradient elution method was used, with the volume ratio of DCM to MeOH gradually changing from 99:1 to 95:5.
[0041] The amount of sodium methoxide added was 3.0 eq;
[0042] When the OGA glycosidase fluorescent probe was separated and purified by column chromatography, the volume ratio of DCM to MeOH gradually changed from 95:5 to 85:15.
[0043] In a third aspect, the present invention provides the application of OGA glycosidase fluorescent probes, such as their application in the preparation of OGA fluorescent imaging agents, which can be used for in situ OGA-specific imaging in live cells and tissue sections to distinguish between cancerous tissue and adjacent tissue.
[0044] In a fourth aspect, the present invention provides a fluorescence imaging product for OGA detection, comprising the aforementioned OGA glycosidase fluorescent probe. The probe can be loaded onto a chip carrier to form a chip, or it can be used to construct a detection kit. The probe is stored in the kit in powder form or sealed liquid form. In practical applications, the powder is dissolved or the solution is diluted before in situ imaging detection of OGA in cells or tissues is performed.
[0045] The role and effect of invention
[0046] This invention yields a series of novel glycosidase probe structures through chemical modification of the sugar side chain. By structurally modifying the amide bond at position 2 of the natural oxyacetylglucosamine, the compound can be specifically recognized and hydrolyzed by OGA to generate a fluorescent signal. This provides a novel fluorescent probe capable of accurately detecting OGA activity in living cells and tissues, offering a new and effective tool for subsequent research on the physiological and pathological functions of OGA.
[0047] In terms of preparation, the non-natural glycosyl structures of the present invention can be obtained efficiently using inexpensive raw materials and are easy to operate; the method uses a modular synthesis approach, the raw material preparation is simple, the route is fixed, and by coupling sugars and dyes, probes with different activities can be obtained efficiently and screened.
[0048] In terms of effectiveness, the structure of this invention can be specifically recognized by OGA, greatly reducing background interference and enabling in situ imaging of OGA in live cells and tissue sections. Attached Figure Description
[0049] Figure 1 The graphs of molecular-level selectivity experiments in Examples 1, 2 and Comparative Example 1 are shown.
[0050] Figure 2 The results of fluorescence quantification of two probes at different concentrations in Examples 1, 2 and Comparative Example 1 after incubation on HeLa cells for 1 hour are shown.
[0051] Figure 3 The results of fluorescence quantification of two probes at different concentrations in Examples 1, 2 and Comparative Example 1 after incubation on HeLa cells for 2 hours are shown.
[0052] Figure 4 The OGA selectivity test plots of the live cell level probes in Examples 1, 2 and Comparative Example 1 are shown.
[0053] Figure 5 The clinical slides incubated with probes and immunofluorescence imaging are shown in Examples 1, 2 and Comparative Example 1. Detailed Implementation
[0054] Experimental methods in the following examples, unless otherwise specified, are generally performed under standard conditions or as recommended by the manufacturer. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of skill in the art. Furthermore, any methods and materials similar or equivalent to those described herein may be used in this invention. The preferred embodiments and materials described herein are for illustrative purposes only.
[0055] I. Probe Preparation
[0056] All purchased chemicals and reagents were of analytical grade. The rapid preparative chromatograph, flash column (200–300 mesh), and C18 separation column were purchased from Suntek Technology Co., Ltd. The NMR instrument used for compound characterization was a Bruker AM 400 MHz. All deuterated reagents used in NMR assays contained 0.03% tetramethylsilane (TMS) as a reference. Fluorescence assays were performed using an M5 microplate reader. Cell imaging was performed using a Leica STELLARIS DMI 8 and a high-content imaging system.
[0057] Example 1: Preparation of probes by linking non-natural GlcNAc structures to the fluorescent dye Rhodol
[0058] This example provides a fluorescent probe, denoted as GlcNBu-Rd, with the following structural formula:
[0059]
[0060] The probe synthesis route is as follows:
[0061]
[0062] The specific steps for synthesizing the fluorescent probe in this embodiment are as follows:
[0063] A magnetic ball, cesium carbonate (103 mg, 0.315 mmol, 5.0 eq), and anhydrous sodium sulfate (36 mg, 0.252 mmol, 4.0 eq) were added to a Shrek tube. The air in the system was replaced three times with argon gas in a double-row tube to prepare an anhydrous and oxygen-free reaction environment. A non-natural GlcNAc structure (Formula 1, 50 mg, 0.127 mmol, 2.0 eq) was dissolved in 2 mL of anhydrous acetonitrile and added to the Shrek tube under an argon atmosphere. Stirring was started to ensure thorough mixing of the reactants. Rhodol dye (24 mg, 0.063 mmol, 1 eq) was dissolved in 2 mL of anhydrous acetonitrile and added to the Shrek tube under an argon atmosphere. The reaction was carried out overnight at room temperature under argon protection with stirring. The reaction progress was monitored by TLC. After the reaction was complete, the acetonitrile was removed by rotary evaporation. Extracted with DCM (100 mL × 3) and saturated brine respectively, the organic phase was collected, dried over anhydrous sodium sulfate, and rotary evaporated to obtain a red oily crude product. The intermediate of the acetyl protected probe was purified by column chromatography (DCM / MeOH = 99:1 → 95:5, v / v). No further purification was performed before proceeding to the next reaction. The acetyl protected probe intermediate was dissolved in 10 mL of methanol solution, and sodium methoxide (10.2 mg, 0.189 mmol, 3.0 eq) was slowly added to the reaction system. The reaction was stirred for 1.5 hours. After the reaction was completed, the methanol was removed by rotary evaporation, and the product was purified by column chromatography (DCM / MeOH = 95:5 → 85:15, v / v) to obtain 1b (20 mg, 0.033 mmol, 52.4%).
[0064] 1H NMR (400 MHz, DMSO-d6) δ 7.73 (dd, J = 9.0, 3.1 Hz, 1H), 7.43 (d, J= 7.6 Hz, 1H), 7.34 (t, J = 7.4 Hz, 1H), 7.23 (t, J = 7.4 Hz, 1H), 6.81 –6.72 (m, 3H), 6.69 – 6.57 (m, 2H), 6.41 (d, J = 8.8 Hz, 1H), 6.35 (s, 1H), 5.24 – 4.94 (m, 5H), 4.65 (s, 1H), 3.76 – 3.62 (m, 2H), 3.62 – 3.54 (m, 1H),3.53 – 3.43 (m, 2H), 3.43 – 3.36 (m, 4H), 3.22 – 3.12 (m, 1H), 2.04 – 1.97 (m, J = 7.1, 5.3, 2.7 Hz, 2H), 1.57 – 1.40 (m, 2H), 1.07 (t, J = 7.0 Hz, 6H), 0.79 (t, J = 6.8 Hz, 1H).
[0065] 13 C NMR (101 MHz, DMSO-d6) δ 172.1, 171.8, 157.8, 150.9, 150.7, 148.2,145.3, 138.8, 129.8, 129.6, 128.2, 127.8, 123.2, 121.1, 119.1, 112.2, 111.3,108.2, 102.8, 99.1, 96.7, 82.7, 77.3, 74.0, 71.4, 70.4, 60.7, 55.1, 43.7,37.8, 18.7, 13.5, 12.4.
[0066] ESI-MS, M / Z (%): calculated as C 34 H 41 N₂O₈ ([M+H)) + ):605.2863(100), 605.2861 was detected.
[0067] Example 2: Preparation of probes by linking non-natural GlcNAc structures to the fluorescent dye Rhodol.
[0068] This embodiment provides a fluorescent probe, denoted as GlcNPr-Rd, with the following structural formula:
[0069]
[0070] The probe synthesis route is as follows:
[0071]
[0072] The specific steps for synthesizing the fluorescent probe in this example are as follows:
[0073] A magnetic ball, cesium carbonate (107 mg, 0.33 mmol, 5.0 eq), and anhydrous sodium sulfate (37 mg, 0.264 mmol, 4.0 eq) were added to a Shrek tube. The air in the system was replaced three times with argon in a double-row tube to prepare an anhydrous and oxygen-free reaction environment. A non-natural GlcNPr structure (Formula 3, 50 mg, 0.132 mmol, 2.0 eq) was dissolved in 2 mL of anhydrous acetonitrile and added to the Shrek tube under an argon atmosphere. Stirring was started to ensure thorough mixing of the reactants. Rhodol dye (25 mg, 0.066 mmol, 1 eq) was dissolved in 2 mL of anhydrous acetonitrile and added to the Shrek tube under an argon atmosphere. The reaction was carried out overnight at room temperature under argon protection with stirring. The reaction progress was monitored by TLC. After the reaction was complete, the acetonitrile was removed by rotary evaporation. Extracted with DCM (100 mL × 3) and saturated brine respectively, the organic phases were collected, dried over anhydrous sodium sulfate, and rotary evaporated to obtain a red oily crude product. The intermediate of the acetyl protected probe was purified by column chromatography (DCM / MeOH = 99:1 → 95:5, v / v). No further purification was performed before proceeding to the next reaction. The acetyl protected probe intermediate was dissolved in 10 mL of methanol solution, and sodium methoxide (10.7 mg, 0.198 mmol, 3.0 eq) was slowly added to the reaction system. The reaction was stirred for 1.5 hours. After the reaction was completed, methanol was removed by rotary evaporation, and the product was purified by column chromatography (DCM / MeOH = 95:5 → 85:15, v / v) to obtain 1a (20 mg, 0.034 mmol, 51.5%).
[0074] 1H NMR (400 MHz, DMSO-d6) δ7.70 (dd, J = 9.1, 3.7 Hz, 1H), 7.45 (d, J= 7.7 Hz, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.24 (t, J = 7.4 Hz, 1H), 6.82 –6.74 (m, 3H), 6.68 – 6.60 (m, 2H), 6.42 (dd, J = 8.9, 2.5 Hz, 1H), 6.36 (s,1H), 5.24 – 5.19 (m, 2H), 5.13 (d, J = 5.5 Hz, 1H), 5.07 (d, J = 5.6 Hz, 1H),4.99 (d, J = 8.4 Hz, 1H), 4.71 – 4.60 (m, 1H), 3.78 – 3.65 (m, 2H), 3.54 –3.46 (m, 1H), 3.44 – 3.36 (m, 2H), 3.33 – 3.28 (m, 4H), 3.23 – 3.16 (m, 1H), 2.11 – 2.01 (m, 2H), 1.08 (t, J = 7.0 Hz, 6H), 1.02 – 0.96 (m, 3H).
[0075] 13 C NMR (101 MHz, DMSO-d6) δ 172.7, 158.4, 151.4, 151.1, 148.6, 145.6,139.2, 130.3, 130.0, 128.6, 128.3, 123.7, 121.5, 119.6, 112.8, 111.7, 108.3,103.2, 99.7, 97.1, 83.4, 78.0, 74.4, 71.8, 70.8, 61.2, 56.1, 44.2, 29.4,12.9, 10.5.
[0076] ESI-MS, M / Z (%): calculated as C 33 H 39 N₂O₈ ([M+H)) + ): 591.2706 (100), 591.2703 was detected.
[0077] Comparative Example 1: Preparation of probes by linking natural GlcNAc structures to the fluorescent dye Rhodol.
[0078] This embodiment provides a fluorescent probe, denoted as GlcNAc-Rd, with the following structural formula:
[0079]
[0080] The probe synthesis route is as follows:
[0081]
[0082] The specific steps for synthesizing the fluorescent probe in this example are as follows:
[0083] A magnetic ball, cesium carbonate (111 mg, 0.34 mmol, 5.0 eq), and anhydrous sodium sulfate (39 mg, 0.272 mmol, 4.0 eq) were added to a Shrek tube. The air in the system was replaced three times with argon gas through a double-row tube to prepare an anhydrous and oxygen-free reaction environment. A natural GlcNAc structure (Formula 2, 50 mg, 0.137 mmol, 2.0 eq) was dissolved in 2 mL of anhydrous acetonitrile and added to the Shrek tube under an argon atmosphere. Stirring was started to ensure thorough mixing of the reactants. Rhodol dye (25 mg, 0.068 mmol, 1 eq) was dissolved in 2 mL of anhydrous acetonitrile and added to the Shrek tube under an argon atmosphere. The reaction was carried out overnight at room temperature under argon protection with stirring. The reaction progress was monitored by TLC. After the reaction was complete, the acetonitrile was removed by rotary evaporation. Extracted with DCM (100 mL × 3) and saturated brine respectively, the organic phases were collected, dried over anhydrous sodium sulfate, and rotary evaporated to obtain a red oily crude product. The intermediate of the acetyl protected probe was purified by column chromatography (DCM / MeOH = 99:1 → 95:5, v / v). No further purification was performed before proceeding to the next reaction. The acetyl protected probe intermediate was dissolved in 10 mL of methanol solution, and sodium methoxide (11 mg, 0.204 mmol, 3.0 eq) was slowly added to the reaction system. The reaction was stirred for 1.5 hours. After the reaction was completed, the methanol was removed by rotary evaporation, and the product was purified by column chromatography (DCM / MeOH = 95:5 → 85:15, v / v) to obtain 1a (21 mg, 0.036 mmol, 53.6%).
[0084] 1H NMR (400 MHz, DMSO-d6) δ 7.86 – 7.80 (m, 1H), 7.44 (d, J = 7.6 Hz,1H), 7.36 (t, J = 7.4 Hz, 1H), 7.24 (t, J = 7.5 Hz, 1H), 6.84 – 6.73 (m, 3H), 6.69 – 6.60 (m, 2H), 6.42 (dd, J = 9.0, 2.5 Hz, 1H), 6.36 (d, J = 2.5 Hz, 1H), 5.20 (s, 2H), 5.16 (d, J = 5.3 Hz, 1H), 5.11 (d, J = 5.3 Hz, 1H), 5.01(d, J = 8.4 Hz, 1H), 4.70 – 4.64 (m, 1H), 3.77 – 3.68 (m, 1H), 3.68 – 3.61 m,1H), 3.53 – 3.46 (m, 1H), 3.46 – 3.39 (m, 2H), 3.34 – 3.28 (m, 4H), 3.21 –3.13 (m, 1H), 1.80 (d, J = 4.2 Hz, 3H), 1.08 (t, J = 6.9 Hz, 6H).
[0085] 13 C NMR (101 MHz, DMSO-d6) δ 169.3, 157.8, 151.0, 150.7, 148.2, 145.3,138.8, 129.8, 129.6, 128.2, 127.9, 123.2, 121.1, 119.2, 112.4, 111.3, 108.2,102.8, 99.1, 96.7, 82.6, 77.3, 74.0, 71.4, 70.3, 60.7, 55.4, 43.7, 23.1,12.4.
[0086] ESI-MS, M / Z (%): calculated as C 32 H 37 N₂O₈ ([M+H)) + ): 577.2550 (100), 577.2551 was detected.
[0087] II. Effect Comparison
[0088] 1. Molecular-level properties of the probe and OGA-specific detection
[0089] Three parallel groups were set up in a 96-well plate. 40 μM of the three probes from Examples 1, 2, and Comparative Example 1 were mixed with OGA (1 ng / μL) and HEX (0.06 U / ml), respectively. Another group was set up with only probes added, without enzymes, as background. The samples were incubated at room temperature for 60 minutes. The excitation wavelength was set to 525 nm, and the fluorescence intensity at 550 nm was read using a fluorescence microplate reader.
[0090] like Figure 1 As shown, Comparative Example 1 probe GlcNAc-Rd showed significant responses to both OGA and HEX, indicating that the natural structure used as a substrate cannot be specifically hydrolyzed by OGA. In contrast, Probes GlcNBu-Rd from Example 1 and GlcNPr-Rd from Example 2 were only recognized by OGA, showing no reaction or significantly reduced reaction with HEX. This demonstrates the OGA-specific recognition performance of the probes of this invention at the molecular level.
[0091] 2. Performance evaluation of live cell probes
[0092] After validating the OGA-specific response of GlcNBu-Rd and GlcNPr-Rd, the imaging capability of the probes was evaluated at the live-cell level. HeLa cells were seeded in clear-bottomed black 96-well plates and cultured overnight. Cells were incubated with different concentrations (0, 5 μM, 10 μM, 20 μM, 40 μM) of the probes at 37 °C and 5% CO2 for 1 and 2 hours, respectively. Selected fields of view were imaged and fluorescence intensity was quantitatively analyzed using the Opera Phenix high-content screening system.
[0093] Imaging results as follows Figure 2 and Figure 3 As shown, all three probes exhibited time- and concentration- and time-dependent fluorescence growth, demonstrating excellent cell imaging capabilities.
[0094] 3. Live-cell in situ OGA specific imaging
[0095] Further investigation was conducted to determine whether the three probes also possessed specificity for OGA at the live-cell level. HeLa cells were seeded in clear-bottomed black 96-well plates and cultured for 24 hours with different concentrations of the OGA-specific inhibitor Thiamet-G (0, 3.70 nM, 11.11 nM, 33.33 nM, 100 nM). Cells were then incubated for 2 hours at 37°C and 5% CO2 with 40 μM of the three probes from Examples 1, 2, and Comparative Example 1, respectively. Selected fields of view were imaged and fluorescence intensity was quantitatively analyzed using the Opera Phenix high-content screening system.
[0096] Imaging results as follows Figure 4The results showed that after TMG specifically inhibited OGA activity, the fluorescence of GlcNBu-Rd and GlcNPr-Rd decreased significantly, consistent with the changes in OGA activity. However, the fluorescence of GlcNAc-Rd remained essentially unchanged, indicating that other enzymes were involved in the cleavage of OGA, generating significant background interference and failing to reflect the true state of OGA. This experiment demonstrates that the probe GlcNBu-Rd achieves specific live-cell fluorescence imaging of OGA.
[0097] 4. Tissue sections enable accurate differentiation of different OGA activities between cancerous and adjacent cancerous tissues.
[0098] The GlcNBu-Rd probe was verified to enable in situ imaging of OGA cells, and its application is expected to be further expanded. Literature reports that OGA activity in HCC cells is weaker than in normal adjacent tissue. Two probes were diluted to 40 μM and uniformly added to the surface of frozen tissue sections from HCC patients. After incubation for 2 hours, full-field imaging was performed using a slide scanner. Immunofluorescence was performed by first treating with OGA antibody (primary antibody) overnight, then adding secondary antibody, incubating and washing, followed by full-field imaging using a slide scanner.
[0099] like Figure 5 As shown, the probe GlcNAc-Rd stained the entire section brightly, making it impossible to distinguish between cancer and adjacent tissue. However, after incubating the section with the probe GlcNBu-Rd, a significant difference was observed between cancer and adjacent tissue. There was almost no fluorescence in the cancer, while there was a clear fluorescent signal in the adjacent tissue, demonstrating that OGA is expressed at low levels in HCC, consistent with the results of OGA immunofluorescence experiments.
[0100] In summary, compared with the natural GlcNAc structure probe, the structurally modified probe GlcNBu-Rd exhibits excellent OGA selectivity at both the molecular and live cell levels, successfully enabling in situ detection of OGA activity in live cells and tissue sections.
[0101] In the above embodiments, a GlcNAc-derived glycosyl group was used as an example to verify its specific binding to OGA. However, other GlcNAc-derived glycosyl groups described in this invention can also achieve the corresponding technical effects and have the same specific binding to OGA, enabling in situ detection of OGA activity in live cells and tissue sections.
[0102] The undescribed parts of this invention are the same as or implemented using existing technology. The applicant declares that this invention is illustrated through the above specific embodiments, but the invention is not limited to the above detailed methods, i.e., it does not mean that the invention must rely on the above detailed methods to be implemented. Those skilled in the art should understand that any improvements to this invention, equivalent substitutions of raw materials for the product of this invention, additions of auxiliary components, and selection of specific methods all fall within the protection and disclosure scope of this invention.
Claims
1. A fluorescent backbone-based OGA glycosidase fluorescent probe, characterized in that, Non-natural GlcNAc structures modified with different structures are attached to the fluorescent dye backbone via O-glycosidic bonds or by introducing a self-sacrificing bridge. Before being recognized by the OGA, the fluorescent backbone is in a closed-ring state. Upon recognition by the OGA, the glycosyl groups are hydrolyzed, thereby converting the dye into a fluorescent open-ring form. The non-natural GlcNAc structure is selected from any of the following structures: , The self-sacrificial bridge structures linked or introduced via O-glycosidic bonds are as follows: R9, R10, R11, and R12 are modifying groups on the benzene ring, with any of the following structures: -H, -NO2.
2. The fluorescent scaffold-based OGA glycosidase fluorescent probe of claim 1, wherein, The fluorescent dye backbone is selected from the Rhodol fluorescent backbone, and the general structural formula of the fluorescent probe is as follows: , In the formula, R1 represents different GlcNAc-derived glycosyl groups, selected from any of the following structures: R2, R3, R4, and R5 are modifying groups on the fluorophore, with specific structures of any of the following: -H, -F, -Cl, -Br; R6 can be modified with other functional groups, specifically any of the following structures: -H, -COOH, -NH2; R7 is the backbone structure at the N-terminus of the dye, specifically any of the following structures: R8 represents a cyclic connection form, specifically any of the following structures: -CH2, -C=O; X is the core structure that affects the optical properties of the dye, and its specific structure can be any of the following: L represents the connection method between sugar and dye, which can be divided into direct connection through O-glycosidic bonds or the introduction of a self-sacrificing bridge structure.
3. A method of preparing an OGA glycosidase fluorescent probe according to claim 1 or 2, characterized in that, Includes the following steps: (1) Add magnetic particles, alkaline catalyst and desiccant to the reaction vessel, and replace the air in the system with inert gas multiple times to prepare an anhydrous and oxygen-free reaction environment; (2) Dissolve GlcNAc derivatized sugars and Rhodol dyes in organic solvents respectively, add them sequentially to the reaction vessel under an inert gas atmosphere, and stir the reaction at room temperature under inert gas protection until complete, and then remove the organic solvent by rotary evaporation. (3) Extraction was performed using organic solvent and saturated brine, respectively. The organic phase was collected, dried with a desiccant, and then rotary evaporated to obtain a red oily crude product. The intermediate of the acetyl protected probe was separated and purified by DCM / MeOH column chromatography. It was directly added to the next reaction without further purification. The intermediate of the acetyl protected probe was dissolved in methanol solution. Sodium methoxide was slowly added to the reaction system and the reaction was stirred. After the reaction was completed by TLC monitoring, methanol was removed by rotary evaporation. The OGA glycosidase fluorescent probe was obtained by separation and purification by DCM / MeOH column chromatography.
4. The method for preparing the OGA glycosidase fluorescent probe according to claim 3, characterized in that, In steps (1) and (3), the desiccant is selected from any one of anhydrous sodium sulfate, anhydrous calcium sulfate, 3A or 4A molecular sieve; In step (1), the equivalent ratio between the alkaline catalyst and the desiccant is 5:4; The alkaline catalyst is selected from either cesium carbonate or potassium carbonate. The inert gas is selected from argon gas used in double-row tubes, and the number of purging cycles is at least 3.
5. The method for preparing the OGA glycosidase fluorescent probe according to claim 3, characterized in that, In step (2), the organic solvent is selected from any one of acetonitrile, methanol, isopropanol, acetone, and tetrahydrofuran; The equivalence ratio of GlcNAc derivatized sugars to Rhodol dye is 2:
1.
6. The method for preparing the OGA glycosidase fluorescent probe according to claim 3, characterized in that, In step (3), the organic solvent is selected from dichloromethane, ethyl acetate, 2-methyltetrahydrofuran, or methyl isobutyl ketone; When separating and purifying the intermediate of the acetyl protected probe by column chromatography, a DCM / MeOH gradient elution method was used, with the volume ratio of DCM to MeOH gradually changing from 99:1 to 95:5; The amount of sodium methoxide added was 3.0 eq; When the OGA glycosidase fluorescent probe was separated and purified by column chromatography, the volume ratio of DCM to MeOH gradually changed from 95:5 to 85:
15.
7. The use of the OGA glycosidase fluorescent probe according to claim 1 or 2 in the preparation of OGA fluorescent imaging agents.
8. A fluorescence imaging product for OGA detection, characterized in that, Includes the OGA glycosidase fluorescent probe as described in any one of claims 1 or 2.
9. The fluorescence imaging product for OGA detection according to claim 8, characterized in that, The product is selected from chips loaded with the probe or detection kits containing the OGA glycosidase fluorescent probe formulation.
10. The fluorescence imaging product for OGA detection according to claim 9, characterized in that, The OGA glycosidase fluorescent probe formulation is selected from either powder or sealed liquid form.
